胡キン

Hu Xin

所属機関・部署：
職名：研究員

研究分野 (4件)：外科学一般、小児外科学 , ウイルス学 , 腫瘍生物学 , 免疫学

競争的資金等の研究課題 (3件)：

2023 - 2025 The research of targeting tumor-associated dendritic cells, a new therapy strategy by dendritic cells mediates uptake of tumor-associated antigens and anti-tumor responses
2021 - 2023 The research of targeting tumor-associated macrophages, a new combination therapy strategy by macrophage polarization and immune checkpoint blockade
2018 - 2020 新規急速液体凍結法「凍眠」を用いた移植用臓器保存法の確立およびその機序の解明

論文 (16件)：

Kuai Ma, Xin Hu, Keiki Nambu, Daisuke Ueda, Naotsugu Ichimaru, Masayuki Fujino, Xiao Kang Li. Coral calcium carried hydrogen ameliorates the severity of non-alcoholic steatohepatitis induced by a choline deficient high carbohydrate fat-free diet in elderly rats. Scientific Reports. 2023. 13. 1
Weitao Que, Hisashi Ueta, Xin Hu, Miwa Morita-Nakagawa, Masayuki Fujino, Daisuke Ueda, Nobuko Tokuda, Wenxin Huang, Wen Zhi Guo, Lin Zhong, et al. Temporal and spatial dynamics of immune cells in spontaneous liver transplant tolerance. iScience. 2023. 26. 9
Yifang Shui, Xin Hu, Hiroshi Hirano, Hirotake Tsukamoto, Wen Zhi Guo, Kenichiro Hasumi, Fumihiro Ijima, Masayuki Fujino, Xiao Kang Li. Combined phospholipids adjuvant augments anti-tumor immune responses through activated tumor-associated dendritic cells. Neoplasia (United States). 2023. 39
Xin Hu, Yifang Shui, Hiroshi Hirano, Kisato Kusano, Wen Zhi Guo, Masayuki Fujino, Xiao Kang Li. PD-L1 antibody enhanced β-glucan antitumor effects via blockade of the immune checkpoints in a melanoma model. Cancer Immunology, Immunotherapy. 2023. 72. 3. 719-731
Weitao Que, Kuai Ma, Xin Hu, Wen Zhi Guo, Xiao Kang Li. Combinations of anti-GITR antibody and CD28 superagonist induce permanent allograft acceptance by generating type 1 regulatory T cells. Science Advances. 2022. 8. 31

講演・口頭発表等 (7件)：

複合リン脂質アジュバントの活性化腫瘍関連樹状細胞を介して抗腫瘍免疫応答を増強する効果
(第82回日本癌学会学術集会)
Supercooling preservation prolonged cold ischemia time in mouse heart transplantation
(第48回日本臓器保存生物医学会学術集会)
Liver mononuclear cells-derived NK cells for treatment of hepatocellular carcinoma
(第51回日本免疫学会学術集会)
PD-L1 antibody enhanced the β-glucan antitumor effects via blockade the immune checkpoints in melanoma model
(第81回日本癌学会学術集会)
Enhancement of antitumor effects of PD-L1 blockade by 5-ALA/SFC via upregulation of metabolism in exhausted T cells in murine melanoma model
(第80回日本癌学会学術集会)

学歴 (1件)：

経歴 (3件)：

受賞 (1件)：

所属学会 (2件)：

日本癌学会 , 日本免疫学会

※　J-GLOBALの研究者情報は、researchmapの登録情報に基づき表示しています。登録・更新については、こちらをご覧ください。

胡 キン